相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Major contribution of tubular secretion to creatinine clearance in mice
Christoph Eisner et al.
KIDNEY INTERNATIONAL (2010)
Abnormal Angiogenesis in Diabetic Nephropathy
Takahiko Nakagawa et al.
DIABETES (2009)
Vascular Endothelial Growth Factor Inhibition by dRK6 Causes Endothelial Apoptosis, Fibrosis, and Inflammation in the Heart via the Akt/eNOS Axis in db/db Mice
Cheol Whee Park et al.
DIABETES (2009)
Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice
Ching-Hsin Ku et al.
DIABETES (2008)
Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition
Debra F. Higgins et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions
Andrew Advani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Angiogenesis inhibitor therapies: Focus on kidney toxicity and hypertension
Hassane Izzedine et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease
Takahiko Nakagawa
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy
Maja T. Lindenmeyer et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice
Cheol Whee Park et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss
H. J. Baelde et al.
KIDNEY INTERNATIONAL (2007)
Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes
Sik Lee et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update
K. O. Alsaad et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Role of the VEGF-A signaling pathway in the glomerulus: Evidence for crosstalk between components of the glomerular filtration barrier
Vera Eremina et al.
NEPHRON PHYSIOLOGY (2007)
Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice
Sun Hee Sung et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Hypertension and antihypertensive treatment of diabetic nephropathy
Eberhard Ritz et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2006)
COMP-angiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model
Won Kim et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man
B Hohenstein et al.
KIDNEY INTERNATIONAL (2006)
Angiogenesis and endothelial cell repair in renal disease and allograft rejection
Marlies E. J. Reinders et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor α
CW Park et al.
DIABETES (2006)
Vascular endothelial growth factor A signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival
Vera Eremina et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat
BF Schrijvers et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy
M Guo et al.
JOURNAL OF ANATOMY (2005)
VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells
D Feliers et al.
KIDNEY INTERNATIONAL (2005)
Arginine-rich anti-vascular endothelial growth factor (anti-VEGF) hexapeptide inhibits collagen-induced arthritis and VEGF-stimulated productions of TNF-α and IL-6 by human monocytes
SA Yoo et al.
JOURNAL OF IMMUNOLOGY (2005)
Nephron number and renal risk in hypertension and diabetes
ML Gross et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Managing patients treated with bevacizumab combination therapy
MS Gordon et al.
ONCOLOGY (2005)
Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy
NH Kim et al.
KIDNEY INTERNATIONAL (2005)
Stimulatory effect of IGF-I and VEGF on eNOS message, protein expression, eNOS phosphorylation and nitric oxide production in rat glomeruli, and the involvement of PI3-K signaling pathway
Y Wang et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2004)
New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology
G Wolf
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2004)
Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy
Y Yamamoto et al.
DIABETES (2004)
The role of vascular endothelial growth factor (VEGF) in renal pathophysiology
BF Schrijvers et al.
KIDNEY INTERNATIONAL (2004)
Diabetic kidney disease in the db/db mouse
K Sharma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2003)
New insights on oxidative stress and diabetic complications may lead to a causal antioxidant therapy
A Ceriello
DIABETES CARE (2003)
Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria
H Sugimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Nephrin expression is reduced in human diabetic nephropathy - Evidence for a distinct role for glycated albumin and angiotensin II
S Doublier et al.
DIABETES (2003)
Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody
A Flyvbjerg et al.
DIABETES (2002)
Biochemistry and molecular cell biology of diabetic complications
M Brownlee
NATURE (2001)
Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide
B Bussolati et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Role of vascular endothelial growth factor in diabetic nephropathy
DR Cha et al.
KIDNEY INTERNATIONAL (2000)
Arginine-rich anti-vascular endothelial growth factor peptides inhibit tumor growth and metastasis by blocking angiogenesis
DG Bae et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
